<DOC>
	<DOCNO>NCT00703742</DOCNO>
	<brief_summary>The purpose study : 1. find structural functional effect selective serotonin reuptake inhibitor ( SSRI ) major depressive disorder ( MDD ) ; 2. find special abnormality depression secondary disease , e.g. , autoimmune disease like systemic lupus erythematosus ( SLE ) . 3. find relationship efficacy antidepressant change neuroimaging MDD 4. find possible predispose MDD 5. explore DNA methylation status depression ;</brief_summary>
	<brief_title>A Neuroimaging Epigenetic Investigation Antidepressants Depression</brief_title>
	<detailed_description>1. explore pathology depression 2. identify difference MDD depression secondary disease , especially autoimmune disease 3. explore effect gene-environment interaction epigenetic regulation depression</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>DSMIV Major Depression Dysthymia Age 1865 Physically healthy Drugfree Body metal ( e.g. , wire stitch , screw bone , stainless steel hip ) History Psychosis Epilepsy Current ( past six month ) Substance Use Disorder ( illicit drug and/or alcohol ) Bipolar I Need washout effective treatment order participate Pregnant High suicide risk Currently take ( within 2 week ; 4 week Fluoxetine ) antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>